Check Your Eligibility
Answer a few questions to see if you may qualify for this trial.
Step 1 of 8
Have you ever received any immune checkpoint inhibitor (ICI) drugs like pembrolizumab, nivolumab, or atezolizumab for your uveal melanoma?
This trial is specifically for patients who have never received checkpoint inhibitor therapy. If you have received these drugs before, you would not be eligible for this study.
Show original medical criteria
Patients must be ICI-naïve (never treated with checkpoint inhibitors) since initial diagnosis
This is informational only — not medical advice. Always discuss eligibility with your oncologist.